Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanink Caro-Vega

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
European Journal of Internal Medicine|September 23, 2022
Harm of early dexamethasone for COVID-19 and bias in randomized trialsIsaac Núñez, Yanink Caro-Vega, Adrian Soto-Mota
Salud Publica De Mexico|October 2, 2014
Socioeconomic status and misperception of body mass index among Mexican adultsM Arantxa Colchero, Yanink Caro-Vega, Martha Kaufer-Horwitz
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|January 17, 2022
Result Turnaround Time of RT-PCR for SARS-CoV-2 is the Main Cause of COVID-19 Diagnostic Delay: A Country-Wide Observational Study of Mexico and ColombiaIsaac Núñez, Pablo F Belaunzarán-Zamudio, Yanink Caro-Vega
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|April 16, 2021
Impact of RT-PCR Test False-Negative Results for SARS-CoV-2 Surveillance in MexicoIsaac Núñez, Pablo F. Belaunzarán-Zamudio, Yanink Caro-Vega
Salud Publica De Mexico|September 27, 2012
High prevalence of late diagnosis of HIV in Mexico during the HAART eraBrenda Crabtree-Ramírez, Yanink Caro-Vega, Francisco Belaunzarán-Zamudio, et al.
International Journal of Epidemiology|November 9, 2025
Target-trial specification as a feasibility check: can we emulate a target trial to evaluate the effect of age at first-time pregnancy on mortality?Isaac Núñez, José Luis Rodríguez-Olivares, Jesús Alegre Díaz, et al.
AIDS and Behavior|October 3, 2023
Challenges to the HIV Care Continuum During the COVID-19 Pandemic in Mexico: A Mixed Methods StudyIsaac Núñez, Ana Amuchastegui, Alejandra Vásquez-Salinas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2020
Clinical Characteristics and Mortality of Health-Care Workers With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Mexico CityLorena Guerrero-Torres, Yanink Caro-Vega, Brenda Crabtree-Ramírez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 24, 2011
Different baseline characteristics and different outcomes of HIV-infected patients receiving HAART through clinical trials compared with routine care in MexicoAlondra López-Martínez, Nathan M O'Brien, Yanink Caro-Vega, et al.
European Journal of Internal Medicine|January 22, 2025
Comparative effectiveness of bictegravir versus dolutegravir, raltegravir, and efavirenz-based antiretroviral therapy among treatment-naïve individuals with HIVIsaac Núñez, Yanink Caro-Vega, Conor MacDonald, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
European Journal of Internal Medicine|September 23, 2022
Harm of early dexamethasone for COVID-19 and bias in randomized trialsIsaac Núñez, Yanink Caro-Vega, Adrian Soto-Mota
Salud Publica De Mexico|October 2, 2014
Socioeconomic status and misperception of body mass index among Mexican adultsM Arantxa Colchero, Yanink Caro-Vega, Martha Kaufer-Horwitz
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|January 17, 2022
Result Turnaround Time of RT-PCR for SARS-CoV-2 is the Main Cause of COVID-19 Diagnostic Delay: A Country-Wide Observational Study of Mexico and ColombiaIsaac Núñez, Pablo F Belaunzarán-Zamudio, Yanink Caro-Vega
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|April 16, 2021
Impact of RT-PCR Test False-Negative Results for SARS-CoV-2 Surveillance in MexicoIsaac Núñez, Pablo F. Belaunzarán-Zamudio, Yanink Caro-Vega
Salud Publica De Mexico|September 27, 2012
High prevalence of late diagnosis of HIV in Mexico during the HAART eraBrenda Crabtree-Ramírez, Yanink Caro-Vega, Francisco Belaunzarán-Zamudio, et al.
International Journal of Epidemiology|November 9, 2025
Target-trial specification as a feasibility check: can we emulate a target trial to evaluate the effect of age at first-time pregnancy on mortality?Isaac Núñez, José Luis Rodríguez-Olivares, Jesús Alegre Díaz, et al.
AIDS and Behavior|October 3, 2023
Challenges to the HIV Care Continuum During the COVID-19 Pandemic in Mexico: A Mixed Methods StudyIsaac Núñez, Ana Amuchastegui, Alejandra Vásquez-Salinas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2020
Clinical Characteristics and Mortality of Health-Care Workers With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Mexico CityLorena Guerrero-Torres, Yanink Caro-Vega, Brenda Crabtree-Ramírez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 24, 2011
Different baseline characteristics and different outcomes of HIV-infected patients receiving HAART through clinical trials compared with routine care in MexicoAlondra López-Martínez, Nathan M O'Brien, Yanink Caro-Vega, et al.
European Journal of Internal Medicine|January 22, 2025
Comparative effectiveness of bictegravir versus dolutegravir, raltegravir, and efavirenz-based antiretroviral therapy among treatment-naïve individuals with HIVIsaac Núñez, Yanink Caro-Vega, Conor MacDonald, et al.
Pageof 6